| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/06/2011 | WO2011000263A1 Fibrinogenolytic enzyme tabfiblysin of horsefly, tabanus yao, encoding gene and use thereof |
| 01/06/2011 | WO2011000058A1 A method of preparation of a biological particulate structure |
| 01/06/2011 | WO2010132690A3 Compositions and methods for promoting tissue repair and wound healing |
| 01/06/2011 | WO2010121351A8 Use of (hexenoyl trans-3)hgrf(1-44)nh2 and ritonavir in combination therapy |
| 01/06/2011 | WO2010117800A3 Shh regulation and methods thereof |
| 01/06/2011 | WO2010111617A4 Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use |
| 01/06/2011 | WO2010103291A3 Use of factor i for treating diseases involving the complement c3b feedback cycle |
| 01/06/2011 | WO2010101994A3 Gene fusion targeted therapy |
| 01/06/2011 | WO2010099515A3 Apparatus, system, and method for creating immunologically enhanced spaces in-vivo |
| 01/06/2011 | WO2010099477A3 Polypeptide structural motifs associated with cell signaling activity |
| 01/06/2011 | WO2010099219A3 Designer ligands of tgf-beta superfamily |
| 01/06/2011 | WO2010095881A3 Target activated cell/tissue translocation peptide for impermeable compound strategy, and uses thereof |
| 01/06/2011 | WO2010093904A3 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf |
| 01/06/2011 | WO2010091651A4 Novel antimicrobial peptides |
| 01/06/2011 | WO2010090758A3 Diabetes diagnostic, prophylactic, and therapeutic compositions and methods |
| 01/06/2011 | WO2010072621A3 Process for the preparation of a peptide powder form |
| 01/06/2011 | WO2010033285A3 Method for treating and preventing radiation damage using genetically modified mesenchymal stem cells |
| 01/06/2011 | WO2009135593A3 Solid pharmaceutical formulation with delayed release |
| 01/06/2011 | WO2009007849A3 Il-23 receptor antagonists and uses thereof |
| 01/06/2011 | US20110004150 Transdermal Delivery Using Encapsulated Agent Activated by Ultrasound and or Heat |
| 01/06/2011 | US20110003973 Antibodies to zalpha11 cytokine receptors |
| 01/06/2011 | US20110003943 Supported Oxidation Reactants, Process for their Preparation and Uses Thereof |
| 01/06/2011 | US20110003844 Regulation of cardiac contractility and heart failure propensity |
| 01/06/2011 | US20110003756 C5a Receptor Antagonists |
| 01/06/2011 | US20110003755 Tumor Endothelial Marker 5-alpha Molecules and Uses Thereof |
| 01/06/2011 | US20110003754 Peptide-Conjugated Oligonucleotide Therapeutic and Method of Making and Using Same |
| 01/06/2011 | US20110003753 COMPOSITIONS AND METHODS FOR DISRUPTING THE FUNCTION OF THE TRANSCRIPTIONAL REPRESSOR COMPONENT Sin3A-PAH2 DOMAIN TO INDUCE DIFFERENTIATION AND GROWTH INHIBITION IN BREAST CANCER |
| 01/06/2011 | US20110003752 New Blood Coagulation Factor Inhibitors |
| 01/06/2011 | US20110003751 Novel Immunoregulatory Peptides, Compositions and Uses Thereof |
| 01/06/2011 | US20110003750 Human 3 relaxin |
| 01/06/2011 | US20110003749 Use of somatostatin or one of its analogues for preparing a medicament intended to regulate the ovarian follicular reserve in non-menopausal women |
| 01/06/2011 | US20110003748 Method of treatment and compositions of D-chiro inositol and phosphates thereof |
| 01/06/2011 | US20110003747 Use of nrf2 inducers to treat epidermolysis bullosa simplex and related diseases |
| 01/06/2011 | US20110003746 Protein variants |
| 01/06/2011 | US20110003745 Granulate-matrix |
| 01/06/2011 | US20110003744 Glycopegylated Erythropoietin Formulations |
| 01/06/2011 | US20110003743 Stem cell derived factors for treating pathologic conditions |
| 01/06/2011 | US20110003742 Naphthalimide Dosing by N-Acetyl Transferase Genotyping |
| 01/06/2011 | US20110003741 Novel neurturin conjugates for pharmaceutical use |
| 01/06/2011 | US20110003740 Insulin sensitisers and methods of treatment |
| 01/06/2011 | US20110003739 Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
| 01/06/2011 | US20110003738 Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof |
| 01/06/2011 | US20110003737 Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
| 01/06/2011 | US20110003735 Peptide derivative fusion inhibitors of hiv infection |
| 01/06/2011 | US20110003734 Proteins and polynucleotides of vibrio cholerae |
| 01/06/2011 | US20110003733 Reconstituted surfactant composition containing analogs of surfactant protein b (sp-b) and surfactant protein c (sp-c) |
| 01/06/2011 | US20110003388 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells |
| 01/06/2011 | US20110003385 Regulated transcription of targeted genes and other biological events |
| 01/06/2011 | US20110003378 MULTIPLE PROMOTER EXPRESSION CASSETTES FOR SIMULTANEOUS DELIVERY OF RNAi AGENTS |
| 01/06/2011 | US20110003340 Synthetic genes for plant gums and other hydroxyproline-rich proteins |
| 01/06/2011 | US20110003339 Pathogenic Escherichia Coli Associated Protein |
| 01/06/2011 | US20110003318 Nucleotide and protein sequence of mammastatin and methods of use |
| 01/06/2011 | US20110003016 Hair care composition |
| 01/06/2011 | US20110003013 Method of increasing metabolism |
| 01/06/2011 | US20110003007 Microparticle and pharmaceutical composition thereof |
| 01/06/2011 | US20110003004 Method of Drug Formulation Based on Increasing the Affinity of Active Agents for Crystalline Microparticle Surfaces |
| 01/06/2011 | US20110003002 Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers |
| 01/06/2011 | US20110002994 Method of regulating the th17 pathway and its associated metabolic impact |
| 01/06/2011 | US20110002984 Formulations comprising exine shells |
| 01/06/2011 | US20110002983 Compound |
| 01/06/2011 | US20110002981 MCPIP Protection Against Cardiac Dysfunction |
| 01/06/2011 | US20110002980 Vaccines using nucleic acid-lipid complexes |
| 01/06/2011 | US20110002978 Enzyme prodrug cancer therapy selectively targeted to tumor cells or tumor vasculature and methods of production and use thereof |
| 01/06/2011 | US20110002972 Neuroendocrine factors for treatment of degenerative diseases |
| 01/06/2011 | US20110002969 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors |
| 01/06/2011 | US20110002963 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (gbm) and other cancers |
| 01/06/2011 | US20110002956 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/06/2011 | US20110002952 FUSED HETEROARYL MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kappaB ACTIVITY AND USE THEREOF |
| 01/06/2011 | US20110002946 Immunostimulatory Combinations |
| 01/06/2011 | US20110002944 Compositions and Methods to Promote Neural Cell Growth |
| 01/06/2011 | US20110002941 Antibodies that Specifically Bind Hedgehog-Derived Polypeptides |
| 01/06/2011 | US20110002938 Hematopoietic cells expressing the protein krtcap3 and ligands for the protein krtcap3 |
| 01/06/2011 | US20110002928 Uses of Mammalian Cytokine; Related Reagents |
| 01/06/2011 | US20110002923 Methods of inhibiting tumor growth using ttk antagonists |
| 01/06/2011 | US20110002921 Combination cancer immunotherapy with co-stimulatory molecules |
| 01/06/2011 | US20110002920 Combination cancer immunotherapy with co-stimulatory molecules |
| 01/06/2011 | US20110002919 Antagonists of neuropilin receptor function and use thereof |
| 01/06/2011 | US20110002918 Methods of treating diseased tissue |
| 01/06/2011 | US20110002915 Random and non-random alkylene oxide polymer alloy compositions |
| 01/06/2011 | US20110002914 Hybrid tetnus toxoid proteins that migrate retrogradely and transynaptically into the cns |
| 01/06/2011 | US20110002913 Use of interleukin-4 antagonists and compositions thereof |
| 01/06/2011 | US20110002912 Composition |
| 01/06/2011 | US20110002910 Therapeutic agents comprising pro-apoptotic proteins |
| 01/06/2011 | US20110002909 Method, composition, and article of manufacture for providing alpha-1 antitrypsin |
| 01/06/2011 | US20110002908 Treatment of a-galactosidase a deficiency |
| 01/06/2011 | US20110002907 Methods, Systems, Compositions And Dosage Forms For Diagnosing And Treating Male Infertility |
| 01/06/2011 | US20110002906 Purification and Isolation of Recombinant Oxalate Degrading Enzymes and Spray-Dried Particles Containing Oxalate Degrading Enzymes |
| 01/06/2011 | US20110002894 Compositions and methods for treating and preventing heart tissue degeneration and uses thereof |
| 01/06/2011 | US20110002893 Diagnosis and treatment of congenital heart defects using nell1 |
| 01/06/2011 | US20110002890 Treatment of tumors with genetically engineered herpes virus |
| 01/06/2011 | US20110002888 Albumin Fusion Proteins |
| 01/06/2011 | US20110002887 Combinations of antibodies selective for dr5 and other therapeutic agents |
| 01/06/2011 | US20110002886 Tetrahydrofuro [3,4-d] dioxolane compounds for use in the treatment of viral infections and cancer |
| 01/06/2011 | US20110002885 Methods of using isolated recombinant polypeptide antagonists of sdf-1 |
| 01/06/2011 | US20110002884 Therapeutic compounds |
| 01/06/2011 | US20110002883 Therapeutic preparations containing wharton's jelly |
| 01/06/2011 | US20110002882 Methods of treating cancer using il-21 |
| 01/06/2011 | US20110002881 Treatment and prophylaxis |
| 01/06/2011 | US20110002880 Material For Wound Healing and Skin Reconstruction |
| 01/06/2011 | US20110002879 Combinations of Pyrazole Kinase Inhibitors |